If you have multiple sclerosis (MS), you may have heard of another autoimmune neurological condition called chronic inflammatory demyelinating polyneuropathy (CIDP). But what is CIDP?
While both are autoimmune diseases that affect the nervous system, they damage different parts of it. CIDP affects the peripheral nerves, which are outside the brain and spinal cord. MS affects the central nervous system, which includes the brain and spinal cord.
Keep reading to learn more about CIDP and how it differs from MS.
CIDP is an autoimmune disorder of the peripheral nervous system. It’s a rare condition that causes progressive muscle weakness, numbness, reduced reflexes, and loss of mobility.
The disease develops slowly, over at least eight weeks, and can go away and come back. It affects people of all ages, with most people diagnosed between ages 40 and 60.
The abbreviation CIDP stands for chronic inflammatory demyelinating polyneuropathy:
Both MS and CIDP occur when your immune system attacks the myelin sheaths around your nerves. In MS, however, this damage happens to cells in your brain and spinal cord. With CIDP, the autoimmune attack damages the peripheral nerves — the nerves throughout your body outside the brain and spinal cord.
While some symptoms of MS and CIDP can look similar, there are key differences that help tell the diseases apart. Both MS and CIDP can cause dizziness, balance and coordination problems, decreased sensation, numbness, tingling, weakness, and loss of mobility.
Muscle weakness is a key symptom of both CIDP and MS. However, with MS, muscle weakness usually affects one side of your face or body, or below your waist.
With CIDP, weakness usually affects both sides of your body equally and usually impacts the hips, thighs, shoulders, upper arms, hands, and feet. Tremors are also possible in both diseases.
Additionally, reflexes are brisk in MS but decreased or absent in CIDP.
Both MS and CIDP commonly cause numbness, tingling, and nerve pain. These are core symptoms for CIDP, but with MS, they don’t always happen.

In MS, these sensations may affect only one side of your face or body, whereas in CIDP, they’re more likely to affect both sides the same. Prickling in your fingers and toes is more characteristic of CIDP than it is of MS.
One MyMSTeam member described the tingling sensation this way: “I swatted ants off my legs all day that weren’t there. This is a new symptom for me.”
Fatigue is common in CIDP. Fatigue is also very common in MS, although the exact percentage can differ depending on how fatigue is measured. In people with MS, fatigue may worsen as the day goes on and in warm or humid weather.
MS and CIDP can both cause problems with balance and coordination. These symptoms could be written off as simple clumsiness, but it’s important to look into them. If you are stumbling, falling, or dropping things more than usual, it’s a good idea to talk to a healthcare professional.
Certain symptoms that are typical of MS are not common in CIDP. These include:
Neither CIDP nor MS can be diagnosed with a single test. For both conditions, it’s often necessary to do a variety of tests to rule out other diseases that might look similar. 
The tests used to diagnose CIDP may be different from many of the tests used to diagnose MS.
In addition to a complete physical and neurological exam, the following tests may be used.
MS and CIDP both can be difficult to diagnose. Studies point to a lot of overdiagnosis of CIDP, and many people with MS describe a long road to finally receiving a correct diagnosis.
Although the treatment and diagnosis of MS have advanced a lot in the past decade, it’s still fairly common to experience misdiagnosis. One study found that up to 30 percent of people who were initially told they had MS were ultimately diagnosed with something else.
More than 50 percent of these people had been living with the misdiagnosis for over three years, and 70 percent had already started MS disease-modifying therapies, which can be expensive and even unhealthy if you don’t actually need them.

Because no single test can confirm MS, getting a diagnosis can take a long time and feel overwhelming. Delays may happen when providers aren’t familiar with MS, when a person has other conditions with similar symptoms, or when specialist appointments take a long time to schedule.
Before 2001, it was common for an MS diagnosis to take four years or more. Now, the average is about a year, but many MyMSTeam members still report struggling to be properly diagnosed.
Many members have mentioned CIDP as a condition that they were either diagnosed with incorrectly or that they should have been diagnosed with and weren’t.
CIDP can be hard to diagnose for some of the same reasons as MS. There’s no clear single test that says whether you have it. CIDP can also affect people in many different ways.
One 2015 review of all previously diagnosed CIDP cases at a large hospital found that nearly half of them (47 percent) did not actually have CIDP. If you are unsure about your care or feel like you aren’t being heard about your symptoms, it may be a good idea to seek another opinion.
“My neurologist has had me going in all different directions now for two years. I have MS, then I don’t have MS, then I have fibromyalgia, then I don’t have fibromyalgia. First, I had CIDP; now I don’t have CIDP. I am so confused!” said one member.
“I was misdiagnosed for at least 20 years before I was finally diagnosed with MS,” said another.
“I have CIDP as well as MS. Some of the time, I can’t even tell what each symptom is caused by because there are so many things mixed up with each other. It drives me bananas,” said one member.
“I have both RA and OA as well as lupus, Sjögren’s, and CIDP in addition to MS. I joke that I am trying to set the Guinness world record for old ladies with autoimmune diseases,” another member said.
CIDP and MS are treated in different ways.
Common first treatments for CIDP include intravenous immunoglobulin (IVIG) and corticosteroids. Plasma exchange (plasmapheresis) may be used if those treatments don’t work well enough or aren’t a good fit. Some people also use subcutaneous immunoglobulin as a maintenance treatment after IVIG helps improve their symptoms.
Treatment options for MS include disease-modifying therapies, which slow MS progression, reduce relapses, and prevent new lesions, as well as other treatments that manage symptoms.
Symptom-management treatments can include:
On MyMSTeam, people share their experiences with multiple sclerosis, get advice, and find support from others who understand.
Do you have CIDP? Were you misdiagnosed with CIDP or MS before getting an accurate diagnosis? Let others know in the comments below.
Get updates directly to your inbox.
Become a member to get even more
This is a member-feature!
Sign up for free to view article comments.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.